EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh

Junichi Ishigami iD, Md Mahmudul Hasan, Aruna Sarker, Sharmin Nahar, Sibly Sadik Shuvo, Mir Ishraquzzaman, Mohammad Abdullah Al Mamun, Md Kalimuddin, Sheikh Mohammad Mahbubus Sobhan, Di Zhao, Kunihiro Matsushita, Lawrence J Appel und 3 weitere

Global Heart · 2025

DOI: 10.5334/gh.1415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Heart, 2025. Verfasst von Junichi Ishigami und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, US. Hauptthemen laut MEDLINE: Hypertension, Amlodipine, Telmisartan, Blood Pressure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The World Health Organization recommends fixed-dose combination (FDC) pills for treating hypertension. Antihypertensive FDC pills often contain a renin-angiotensin inhibitor (RASI) or diuretic. Thus, screening and monitoring for dyskalemia (hypokalemia or hyperkalemia) before and after starting these classes of medications are recommended, a significant barrier for implementation in resource-limited settings. However, the need for blood tests may be overemphasized if the prevalence of dyskalemia in patients with hypertension is uncommon and the incidence of dyskalemia is rare after initiation of FDC.

Methods

We conducted a community-based blood pressure (BP) screening program in Dhaka, Bangladesh, and determined the prevalence of dyskalemia, as defined by K < 3.0 or K > 5.5 mmol/L, in untreated adults with SBP ≥140 mmHg and/or DBP ≥90 mmHg. Among those with a baseline serum K of ≥3.0 or ≤5.0 mmol/L and creatinine clearance ≥30 ml/min, we determined the incidence of dyskalemia 2 months after initiation of a daily FDC of telmisartan 40 mg and amlodipine 5 mg. Secondary outcomes were BP change, medication adherence, and symptoms.

Results

In 2022–2023, we recruited 1,073 adults with SBP ≥140 mmHg and/or DBP ≥90 mmHg. The mean age was 54 years, with 71% men and mean baseline BP 157/94 (SD 12/9.3) mmHg. The prevalence of hypokalemia and hyperkalemia was 1.6% and 0.2%, respectively. FDC was initiated in 1,017 eligible patients, and 864 completed the 2-month follow-up visit. Incident hypokalemia occurred in 1.5% of patients, but there was no case of incident hyperkalemia. The mean change in serum potassium after initiating FDC was –0.05 (0.53) mmol/L. At follow-up, 92% had BP

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionAmlodipineTelmisartanBlood PressureHypokalemiaHyperkalemiaHumansMaleFemaleBangladeshMiddle AgedAntihypertensive AgentsDrug CombinationsAdultIncidencePrevalenceFollow-Up Studies

Stichwörter der Autor:innen

Fixed-dose combinationHyperkalemiaHypertensionHypokalemia

Substanzen

AmlodipineTelmisartanAntihypertensive AgentsDrug Combinations

Autor:innen und Institutionen

  • Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, US.
  • Department of Medicine, Johns Hopkins University School of Medicine, US.
  • Department of Epidemiology & Research, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
  • Department of Cardiology, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.

ORCID-Profile: Junichi Ishigami, Edgar R Miller

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Ishigami, J., Hasan, M. M., Sarker, A., Nahar, S., Shuvo, S. S., Ishraquzzaman, M., Al Mamun, M. A., Kalimuddin, M., Mahbubus Sobhan, S. M., Zhao, D., Matsushita, K., Appel, L. J., Choudhury, S. R., Miller, E. R., & Malik, F. T. (2025). Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh. Global Heart. https://doi.org/10.5334/gh.1415

Vancouver

Ishigami J, Hasan MM, Sarker A, Nahar S, Shuvo SS, Ishraquzzaman M, et al. Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh. Global Heart. 2025. doi:10.5334/gh.1415

BibTeX
@article{Ishigami2025,
  author = {Ishigami, Junichi and Hasan, Md Mahmudul and Sarker, Aruna and Nahar, Sharmin and Shuvo, Sibly Sadik and Ishraquzzaman, Mir and Al Mamun, Mohammad Abdullah and Kalimuddin, Md and Mahbubus Sobhan, Sheikh Mohammad and Zhao, Di and Matsushita, Kunihiro and Appel, Lawrence J and Choudhury, Sohel Reza and Miller, Edgar R and Malik, Fazila-Tun-Nesa},
  title = {Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh},
  journal = {Global Heart},
  year = {2025},
  doi = {10.5334/gh.1415}
}
Kostenlos starten →